Read here for an insight from the STV News show, Scotland Tonight, with our CEO and Founder, Prof Craig Ritchie, about the lifechanging potential for research to help detect Alzheimer’s early & treat before it progresses to dementia.
Prevention, risk factors, action plans for healthier brain
Please join us in welcoming Dr Sarah Gregory to the SBS Team as IONA National Coordinator! Read more about what she brings to Scottish Brain Sciences…
At the intersection of Sport Science and Psychology: meet Scottish Brain Sciences’ Head of Sports Science.
An agreement between Scottish Brain Sciences and a global leader in precision diagnostics is aiming to transform the ability of clinicians to identify the very earliest signs of Alzheimer’s Disease – long before symptoms can be seen.
Professor Craig Ritchie has told an international Alzheimer’s conference that phase 3 clinical trial results for donanemab, the antibody drug designed to target and clear the amyloid plaques considered key to progression of Alzheimer’s disease, reveal the drug’s “profound” clinical effect.
Professor Craig Ritchie, CEO of Scottish Brain Sciences co-hosts the second international brain health summit in St Andrew’s, bringing together experts across the NHS, academia, and industry for a two-day conference.
With visits to both Boston, Massachusetts for the BIO Convention, as well as San Francisco, California, for an exciting Life Sciences reception, June 2023 was a big month for Scottish Brain Sciences. And one that also promised big things on the horizon!
Professor Ritchie spoke with The Times about the drive to advance research at a faster pace than manageable within the NHS.